MedTrace Logo

Imaging Feature of SARS-CoV2 Infection

NCT04394026 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-01-26

No results posted yet for this study

Summary

The novel coronavirus SARS-CoV2 clinically presents with pneumonia, characterised by fever, cough, dyspnea. The severity of the disease varies widely with evidence of mild disease in the majority of confirmed cases, severe pneumonia-dyspnea, hypoxia or lung involvement at imaging within 24-48 hours- and critical disease with respiratory failure, shock or multi-organ failure in particular patient cohorts. Imaging plays a key role is diagnosis and progression of this disease.

Conditions

Sponsors & Collaborators

  • Francesco De Cobelli

    lead OTHER

Principal Investigators

  • Carlo Martinenghi, MD · IRCCS Ospedale San Raffaele

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-16
Primary Completion
2021-12-30
Completion
2021-12-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04394026 on ClinicalTrials.gov